Quarterly report pursuant to Section 13 or 15(d)

Segments - Operations and Assets Information (Details)

v3.19.3
Segments - Operations and Assets Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Segment Reporting Information [Line Items]          
Total revenues $ 228,772 $ 249,815 $ 677,592 $ 768,412  
Operating loss (39,011) (33,464) (161,588) (81,184)  
Depreciation and amortization 23,805 23,921 71,281 73,440  
Net income (loss) from investment in investees (294) (1,874) (2,419) (11,542)  
Assets 2,369,518   2,369,518   $ 2,451,072
Goodwill 695,798   695,798   700,193
United States          
Segment Reporting Information [Line Items]          
Total revenues 189,485 208,646 558,688 646,492  
Ireland          
Segment Reporting Information [Line Items]          
Total revenues 22,968 24,407 65,675 62,468  
Chile          
Segment Reporting Information [Line Items]          
Total revenues 8,436 8,926 25,352 32,596  
Spain          
Segment Reporting Information [Line Items]          
Total revenues 4,172 4,144 13,466 14,269  
Israel          
Segment Reporting Information [Line Items]          
Total revenues 1,938 2,283 8,822 8,424  
Mexico          
Segment Reporting Information [Line Items]          
Total revenues 1,642 1,382 5,231 4,105  
Other          
Segment Reporting Information [Line Items]          
Total revenues 131 27 358 58  
Corporate          
Segment Reporting Information [Line Items]          
Operating loss (8,416) (5,445) (31,378) (25,839)  
Depreciation and amortization 16 20 54 71  
Net income (loss) from investment in investees 0 0 0 0  
Assets 19,520   19,520   52,413
Goodwill 0   0   0
Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Operating loss (14,232) (16,937) (52,265) (37,721)  
Depreciation and amortization 7,673 7,021 22,580 20,514  
Net income (loss) from investment in investees (294) (1,603) (2,419) (10,715)  
Assets 1,235,513   1,235,513   1,236,499
Goodwill 243,011   243,011   247,407
Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Operating loss (16,363) (11,082) (77,945) (17,624)  
Depreciation and amortization 16,116 16,880 48,647 52,855  
Net income (loss) from investment in investees 0 (271) 0 (827)  
Assets 1,114,485   1,114,485   1,162,160
Goodwill 452,787   452,787   $ 452,786
Services          
Segment Reporting Information [Line Items]          
Total revenues 181,139 202,811 538,488 630,180  
Services | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Services | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Services | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 181,139 202,811 538,488 630,180  
Products          
Segment Reporting Information [Line Items]          
Total revenues 26,161 25,395 80,143 81,769  
Products | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 26,161 25,395 80,143 81,769  
Transfer of intellectual property and other          
Segment Reporting Information [Line Items]          
Total revenues 21,472 21,609 58,961 56,463  
Transfer of intellectual property and other | Corporate          
Segment Reporting Information [Line Items]          
Total revenues 0 0 0 0  
Transfer of intellectual property and other | Pharmaceutical | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues 21,472 21,609 58,961 56,463  
Transfer of intellectual property and other | Diagnostics | Operating Segments          
Segment Reporting Information [Line Items]          
Total revenues $ 0 $ 0 $ 0 $ 0